CLINICAL_TRIALS
withdrawal
· 2021-12-15
Clinical Trial Update: Assessment of Intravenous Rate Control Response in Atrial Fibrillation Trial (AIRCRAFT) [Phase 4]
Summary
Phase 4 trial AIRCRAFT evaluating intravenous rate control in atrial fibrillation has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Boston University | Conditions: Atrial Fibrillation | Phase 4 | Status: WITHDRAWN